Hemoglobinopathies Market - Global Industry Analysis
Hemoglobinopathies Market: by Indication (sickle cell disease, alpha thalassemia, beta thalassemia and others), Therapy (blood transfusion, iron chelation therapy, bone marrow transplant, and others), Diagnosis (blood testing, genetic testing, pre-implantation genetic diagnosis (PGD) and others), End user (Hospitals, Diagnostic laboratories, Clinics, Other End-user) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025
Published Date: 24-Oct-2019Healthcare
Category: Report Format : PDF
Report Code: ZMR-4918
Status : Published
According to the report, global demand for Hemoglobinopathies market was valued at approximately USD 5,790.0 million in 2018, and is expected to generate revenue of around USD 11,409.84 million by end of 2025, growing at a CAGR of around 10.25% between 2019 and 2025.